September 28, 2016
Why big pharma wants to collect 2 million genomes
news@nature.com - Fetched: September 28th, 2016, 12:00pm UTC
For the head of AstraZeneca’s genomics initiative, the challenge is not just getting the sequences, but in putting them to use — wisely.
Nature News doi: 10.1038/nature.2016.20697